A clinical trial of SAL007 [JK-07] to treat chronic heart failure with reduced ejection fraction (NYHA II-III)
Latest Information Update: 18 Jul 2022
At a glance
- Drugs JK 07 (Primary)
- Indications Heart failure
- Focus Adverse reactions
- Sponsors SalubrisBio
Most Recent Events
- 18 Jul 2022 New trial record